Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

World Sleep 2022 | Aging, neurodegeneration, and sleep

Aleksandar Videnovic • 24 Mar 2022
World Sleep 2022
Sleep Disorders

Aleksander Videnovic, MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, describes what he feels is the most exciting avenue in neurodegenerative research currently. Analysis of sleep disruptions and associated biomarkers in circadian regulatory systems will likely yield new therapeutic targets for aging, neuropathology, and general brain health. This interview took place during the World Sleep Congress 2022 in Rome, Italy.

More from Aleksandar Videnovic

2:59
New initiatives from NeuroNEXT: clinical trial support for academic and industry partners
Aleksandar Videnovic • 15 Apr 2024
2:12
Establishing the North American Prodromal Synucleinopathy (NAPS) consortium
Aleksandar Videnovic • 15 Apr 2024
2:45
The importance of disease modifying therapy in iRBD
Aleksandar Videnovic • 24 Mar 2022
2:47
Current and upcoming clinical trials in iRBD
Aleksandar Videnovic • 24 Mar 2022

Related Videos

1:17
Growing evidence for sleep and brain health
Karin Johnson • 14 Apr 2024
2:12
Establishing the North American Prodromal Synucleinopathy (NAPS) consortium
Aleksandar Videnovic • 15 Apr 2024
1:36
Current treatment options for RBD
Ambra Stefani • 3 Jul 2023
1:04
The diverse effects of antiseizure medications on sleep disorders
Samson Khachatryan • 1 Jul 2023
The content of VJNeurology is intended for healthcare professionals